Literature DB >> 1318488

Microneutralization as a reference method for selection of the cut-off of an enzyme-linked immunosorbent assay for detection of IgG antibody to human cytomegalovirus.

G Gerna1, M G Revello, M Palla, E Percivalle, M Torsellini.   

Abstract

In view of developing an enzyme-linked immunosorbent assay (ELISA) for the determination of IgG antibody to human cytomegalovirus, a rapid microneutralization (Nt) assay was used to test five positive standard sera containing increasing amounts of specific antibody and a negative standard serum. The standard serum containing the minimal amount of detectable Nt antibody was selected as a cut-off standard for the ELISA test. Following preliminary testing on previously characterized sera which gave expected results, the ELISA assay was tested in the field on 992 sera from blood donors. In parallel, sera were tested by Nt and complement fixation (CF). ELISA detected 82 negative and 910 positive sera. Nt gave concordant result except for two ELISA-negative sera, which showed Nt antibody titers of 1:10. The absorbance value of these two sera was just below that of the cut-off. Thus, for ELISA, the sensitivity was 99.8% (910/912) and specificity 100% (80/80). CF gave results concordant with ELISA and Nt, except for 23 sera (2 ELISA- and Nt-negative, and 21 ELISA- and Nt-positive) showing anticomplementary activity. Quantitation of specific ELISA antibody was achieved by interpolation from a calibation curve. Nt appears to be the reference test to establish the ELISA cut-off.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318488

Source DB:  PubMed          Journal:  Microbiologica        ISSN: 0391-5352


  2 in total

1.  Clinical evaluation of a chemiluminescence immunoassay for determination of immunoglobulin g avidity to human cytomegalovirus.

Authors:  Maria Grazia Revello; Giovanna Gorini; Giuseppe Gerna
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

2.  In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.

Authors:  M G Revello; E Percivalle; E Arbustini; R Pardi; S Sozzani; G Gerna
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.